[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy]

[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy] Abstract Text:

O S Brusov,M I Faktor,G P Zlobina,A M Dupin,A B Katasonov,N K Kartseva,A G Beniashvili,N B Zharkova,V V Rubashkina,M A Morozova,

Fifty-nine patients, 21 women and 38 men, with ICD-10 diagnosis of schizophrenia (F20.0), attack-like type, were treated with olanzapine during 28 weeks (8-weeks of acute and 20-weeks of maintenance therapy). Evaluation of clinical symptoms measured by the Positive and Negative Syndromes scale (PANSS) revealed that female patients responded better to therapy as compared to male ones, with PANSS total, PANSS negative and PANSS general psychopathological scores being significantly reduced (p < 0.006) in females after 1 week of the treatment and in males--after 2 weeks. In the female group, a reduction of PANSS total score by 50% in the acute stage of treatment qualified as a very good response was observed in 7 (33%) patients and in the male group--in 1 (2.7%). The between-groups difference was highly significant (p = 0.002). When examined for a rate of 3H-serotonin uptake into platelets, density of sites of 3H-imipramine binding on the whole platelets, platelet serotonin level and levels of high- also low-molecular weight forms of platelet immunoreactive serotonin transporter protein, a significant decrease of the platelet serotonin level, comparing to controls, was detected in the female group before treatment. During the treatment, this parameter gradually increased up to control level. Other parameters did not change significantly for 28-weeks of therapy and did not differ from the control values. There were positive correlations between the levels of platelet serotonin before treatment and subsequent reduction of the PANSS total and positive subscale scores in the female group. In responders with a very good treatment-related response, the serotonin level in the platelets before treatment was higher compared to the values in resistant patients: 5.4 +/- 2.5 and 2.7 +/- 1.3 nmol/10(9) cells, respectively. Relative risk (RR) of unfavorable treatment outcome in patients with initially reduced levels of platelet serotonin was approximately twice lower (RR = 1.83; Cl 95% 1.1-34.9) than that in patients with normal or elevated levels of platelet serotonin. The results suggest that selection of patients with initial higher level of platelet serotonin before olanzapine treatment can reduce the risk of non-responding to therapy by 36%.

[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy] Publishing Authors By Initials

OS Brusov,MI Faktor,GP Zlobina,AM Dupin,AB Katasonov,NK Kartseva,AG Beniashvili,NB Zharkova,VV Rubashkina,MA Morozova,

For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

PUBMED ID PMID:

MEDLINE DATE:

[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsak

VOLUME: 105

Page Numbers: 27-34

Journal Abbreviation:

ISSN: 1997-7298

DAY: 31

MONTH: 03

YEAR: 2005

[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy] Information

Number of References:

LANGUAGE: rus

NlmUniqueID: 9712194

[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy] Keywords Mesh Terms:

KEYWORDS: Time Factors

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: [Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy] Information

Substance Name: Serotonin

Registry Number: 50-67-9

Grant and Affiliation Information for [Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy]

AFFILIATION:

Country: Russia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Zh Nevrol Psikhiatr Im S S Kor

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy Related Publications

• Change in immunologic specificity of tissue proteins of white mice treated with penicillin.
• Effect of repeated ACTH administration on 3-beta-ol-dehydrogenase activity and synthesis of steroids from progesterone in adrenal glands of rabbits.
• Features of absorption and fluorescence spectra of prodan.
• Visual discrimination of size and shape after section of the corpus callosum in rats.
• [A change of immune profile of patients with schizophrenia during treatment]
• [A combination of antidepressants and neuroleptics in the treatment of affective disorders and schizophrenia: indications, side effects and complications]
• [Acariasis]
• [Analysis of spontaneous lung tumors in domestic animals]
• [Assimilation of carbohydrates in calves with dyspepsia]
• [Classification of pathological drives in children and adolescents]
• [Complex Assessment of Episodes of Ischemia and Vasomotor Function of Vascular Endothelium in Patients With Type II Diabetes Mellitus.]
• [Effect of droperidol, fentanyl and talamonal on the ischemic threshold of the myocardium]
• [Effect of thymoleptics in aspects of new clinical systematics of depressive syndrome]
• [Estradiol stimulation of thyrotropic hormone elaboration in cultures of adenohypophysis obtained from intact and ovariectomized rats]
• [Evaluation of the antianginal action of pharmacological substances by the change in the initiation threshold for myocardial ischemia in conscious rabbits]
• [Histomorphology of tumors of the mammary glands in carnivors]
• [Manic-depressive psychosis]
• [Morphometric study of the spleen in C57BL strain mice during pregnancy with syngeneic or allogeneic embryos]
• [Organization of health education at the medical center of the oil refinery]
• [Outbreaks of erysipeloid in pheasants and quails]
• [Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy]
• [Propaganda for a solicitous attitude to bread]
• [Relative drug resistance as a result of an erroneous approach to patient care]
• [Stimulating action of estradiol dipropionate on uterine sarcomagenesis induced by 1,2-dimethylhydrazine in mice]
• [Structural-dynamic analysis of the mechanism of clinical response and treatment prognosis]
• [The basic diet]
• [The basic gastroenterological diet]
• [The determination of enzymes and their significance]
• [The effect of thyroxine and methylthiouracil on the gonadotropic reaction and ability of androgen to stimulate regeneration of cocks' combs]
• [Treatment of hypertension with dibazol.]